First ‘next generation’ genomic test available in six months
Australian patient outcomes in the rapidly changing fields of genomic testing and precision medicine has been accelerated by Leukaemia Foundation funding.
- Myeloma
- Research
Australian patient outcomes in the rapidly changing fields of genomic testing and precision medicine has been accelerated by Leukaemia Foundation funding.
Rebecca's research work is looking at different pathways of NK cells in acute myeloid leukaemia.
Lynn Simpson is now the carer for her son, Darrin, after his shock blood cancer diagnosis.
She was just 24 and had recently immigrated to Australia from Slovakia before she was diagnosed with a rare and aggressive form of blood cancer called lymphoma.
Elle Halliwell found out she was pregnant in early 2016 – two days after being told she had CML.
Kellie and Rita have walked the same path since their diagnoses, but they've had very different experiences.
The Leukaemia Foundation has welcomed news that a new novel combination therapy option will now be available to more myeloma patients through the Pharmaceutical Benefits Scheme (PBS).
Since Chris Davis’ diagnosis with chronic myeloid leukaemia, he’s had three different treatments, endured debilitating side-effects, has taken part in an international clinical trial and is now disease-free.
Luci was a healthy 28-year-old when she wasdiagnosed with a blood disorder leading to a second blood cancer diagnosis.